Novo-Nordisk A/S revenue breakdown overview

Novo-Nordisk A/S revenue for the last year amounted to 40.19 B USD, the most of which — 37.61 B USD — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 31.84 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Novo-Nordisk A/S 23.17 B USD, and the year before that — 18.88 B USD.